Petmed Express to Evaluate Revised Takeover Offer from Silvercape

Dow Jones06-30

PetMed Express said it received and plans to evaluate a revised offer from SilverCape Investments, its largest shareholder, to acquire the company for $3 a share in cash.

The online pet pharmacy said Tuesday it is prepared to engage with SilverCape over the proposal if the firm executes a nondisclosure agreement containing a standstill provision.

PetMed said SilverCape had ultimately been unwilling to execute a nondisclosure agreement containing a standstill provision after months of negotiation over its previous $4-a-share takeover proposal made in December.

PetMed also reiterated that it would consider any credible proposal that it believes could maximize value for stockholders.

SilverCape disclosed its revised offer on Monday. The firm, which owns about 12% of PetMed, said the reduced price reflects what it described as PetMed's continued deterioration, and continues to value the company at a premium to its recent share price.

SilverCape urged PetMed to engage with its revised offer, and said that taking the company private would provide immediate value to shareholders after years of declining share performance. The firm criticized PetMed's performance and accused directors of failing to meaningfully engage with its earlier proposal or run a robust sale process after receiving acquisition interest.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

June 30, 2026 10:40 ET (14:40 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2647552054?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 22:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2647552054","market":"sg","top_or_hot":-1,"title":"Petmed Express to Evaluate Revised Takeover Offer from Silvercape","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/PETS\">PetMed Express</a> said it received and plans to evaluate a revised offer from SilverCape Investments, its largest shareholder, to acquire the company for $3 a share in cash. \n</p>\n<p>\n  The online pet pharmacy said Tuesday it is prepared to engage with SilverCape over the proposal if the firm executes a nondisclosure agreement containing a standstill provision. \n</p>\n<p>\n  PetMed said SilverCape had ultimately been unwilling to execute a nondisclosure agreement containing a standstill provision after months of negotiation over its previous $4-a-share takeover proposal made in December. \n</p>\n<p>\n  PetMed also reiterated that it would consider any credible proposal that it believes could maximize value for stockholders. \n</p>\n<p>\n  SilverCape disclosed its revised offer on Monday. The firm, which owns about 12% of PetMed, said the reduced price reflects what it described as PetMed's continued deterioration, and continues to value the company at a premium to its recent share price. \n</p>\n<p>\n  SilverCape urged PetMed to engage with its revised offer, and said that taking the company private would provide immediate value to shareholders after years of declining share performance. The firm criticized PetMed's performance and accused directors of failing to meaningfully engage with its earlier proposal or run a robust sale process after receiving acquisition interest. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 30, 2026 10:40 ET (14:40 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Petmed Express to Evaluate Revised Takeover Offer from Silvercape</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPetmed Express to Evaluate Revised Takeover Offer from Silvercape\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-30 22:40</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/PETS\">PetMed Express</a> said it received and plans to evaluate a revised offer from SilverCape Investments, its largest shareholder, to acquire the company for $3 a share in cash. \n</p>\n<p>\n  The online pet pharmacy said Tuesday it is prepared to engage with SilverCape over the proposal if the firm executes a nondisclosure agreement containing a standstill provision. \n</p>\n<p>\n  PetMed said SilverCape had ultimately been unwilling to execute a nondisclosure agreement containing a standstill provision after months of negotiation over its previous $4-a-share takeover proposal made in December. \n</p>\n<p>\n  PetMed also reiterated that it would consider any credible proposal that it believes could maximize value for stockholders. \n</p>\n<p>\n  SilverCape disclosed its revised offer on Monday. The firm, which owns about 12% of PetMed, said the reduced price reflects what it described as PetMed's continued deterioration, and continues to value the company at a premium to its recent share price. \n</p>\n<p>\n  SilverCape urged PetMed to engage with its revised offer, and said that taking the company private would provide immediate value to shareholders after years of declining share performance. The firm criticized PetMed's performance and accused directors of failing to meaningfully engage with its earlier proposal or run a robust sale process after receiving acquisition interest. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 30, 2026 10:40 ET (14:40 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4122","symbol_name":"互联网与直销零售","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2647552054","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2647552054","pubTimestamp":1782830400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"PetMed Express said it received and plans to evaluate a revised offer from SilverCape Investments, its largest shareholder, to acquire the company for $3 a share in cash.The online pet pharmacy said T","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4122":"互联网与直销零售","BK4200":"专卖店","PETS":"PetMed Express"},"translate_title":"Petmed Express将评估Silvercape修订后的收购要约","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PETS":0.9},"content_text":"PetMed Express said it received and plans to evaluate a revised offer from SilverCape Investments, its largest shareholder, to acquire the company for $3 a share in cash. \n\n\n  The online pet pharmacy said Tuesday it is prepared to engage with SilverCape over the proposal if the firm executes a nondisclosure agreement containing a standstill provision. \n\n\n  PetMed said SilverCape had ultimately been unwilling to execute a nondisclosure agreement containing a standstill provision after months of negotiation over its previous $4-a-share takeover proposal made in December. \n\n\n  PetMed also reiterated that it would consider any credible proposal that it believes could maximize value for stockholders. \n\n\n  SilverCape disclosed its revised offer on Monday. The firm, which owns about 12% of PetMed, said the reduced price reflects what it described as PetMed's continued deterioration, and continues to value the company at a premium to its recent share price. \n\n\n  SilverCape urged PetMed to engage with its revised offer, and said that taking the company private would provide immediate value to shareholders after years of declining share performance. The firm criticized PetMed's performance and accused directors of failing to meaningfully engage with its earlier proposal or run a robust sale process after receiving acquisition interest. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 30, 2026 10:40 ET (14:40 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2647552054","isCrawlerRequest":true}